DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Geron Corp (NASDAQ: GERN)



company name or ticker

Why Geron, Express, and Herbalife Tumbled Today

The S&P 500 managed to end a two-day losing streak Wednesday with very modest gains, but many stocks couldn't recover from severe losses. Find out what made these three stocks drop today.

Geron Is Dead in the Water, but Not Sunk Yet

When people consider you an oncology company, losing your only oncology drug can sting.

The 4 Stocks That Dominated the Market on Wednesday

Why Geron Corporation Shares Were Mauled

Geron shares are turned upside down after updating the status of its imetelstat development program. Is this dip a buying opportunity or all the more reason to hit the exit?

Back to Normalcy at Geron

Geron, Zogenix, Synta Pharmaceuticals, and Pfizer: Today’s Top Health Care Stories

Geron, Zogenix, Synta Pharmaceuticals, and Pfizer could all make health care headlines this morning. Here’s why.

Use Options For a Chance To Buy GERN at a 52% Discount

Geron: A Biotech Stock With Potential For Long-Term Gains

Geron: Where Did The Shares Go?

Update: Week Ending February 15, 2014